DGAP-News: MagForce AG / Key word(s): Miscellaneous MagForce AG: MagForce AG Publishes its Second Shareholder Letter 2015 08.06.2015 / 11:30 --------------------------------------------------------------------- MagForce AG Publishes its Second Shareholder Letter 2015 Berlin, Germany, and Nevada, USA, June 08, 2015 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, today published its second Shareholder Letter 2015: "Dear MagForce Shareholders, I am pleased to report that we continue to make progress toward achieving our 2015 targets. Brain Cancer NanoTherm(TM) Therapy at MagForce AG Installation of additional NanoActivator(R) devices in Germany to treat Brain Cancer: The installation process of NanoActivator(R) devices in the world class hospitals in Frankfurt and Cologne has been completed. The installation of the sixth NanoActivator(R) at the University Hospital at Göttingen is on schedule and expected to be operational in the third quarter of 2015. At the end of the year we will have six devices operational in Germany and additional centers trained to perform the instillation of the nanoparticles, giving us sufficient capacity to complete enrollment in our Post Marketing Glioblastoma Study and as well as to accomplish our commercial treatment targets through 2017. Commercial NanoTherm(TM) treatments have been performed at three of the NanoActivator(R) clinics so far, providing the opportunity for the medical staff at these sites to determine the optimum medical application of NanoTherm(TM) for the treatment of brain tumors. NanoTherm(TM) therapy has CE certifications for the treatment of all Brain Cancers in contrast to the Post Marketing Study, which focuses on recurrent Glioblastoma, a single and highly malignant form of brain tumor. At the beginning of commercial treatments, our medical colleagues do rightfully proceed with caution as they apply the NanoTherm(TM) therapy to patients. We expect to treat a limited number of patients during the first half of 2015 but accelerate as 2015 progresses. In summary, we will have completed our target of installing and operating six NanoActivators(R) in Germany during the third quarter of 2015. This accomplisment will provide an operational clinical NanoTherm(TM) therapy structure to demonstrate expected medical value of NanoTherm(TM) therapy for the treatment of brain tumors as well as to continue the Post Marketing Study. The MagForce clinical team in Germany is focused solely on the treatment of brain tumors with NanoTherm(TM) therapy at the six world class German hospitals. During the second half of 2015, MagForce AG will expand its efforts to establish a reimbursement structure for commercial NanoTherm(TM) brain therapy in addition to that of private pay. With respect to our expansion phase outside Germany, MagForce USA, Inc. plans to submit an Investigate Device Exemption (IDE) for the treatment of brain cancer with NanoTherm(TM) therapy after the approval has been granted for its IDE for the NanoTherm(TM) treatment of Intermediate Risk Prostate Cancer. Prostate Cancer Therapy at MagForce USA, Inc. Regarding the application of our NanoTherm(TM) therapy for the focal treatment of Prostate Cancer, our unique technology is viewed as a very promising complement to current treatment approaches. In January 2015 an in-person meeting was held with the U.S. Food and Drug Administration's (FDA) Center for Devices and Radiological Health to discuss FDA's response to our NanoTherm(TM) Prostate Cancer Therapy Pre-Submission of November 2014. We received very constructive feedback on our submission and have an understanding of the pathway to market in the USA of our therapy to focally ablate Prostate Cancer. MagForce USA, Inc. has recently filed an Investigational Device Exemption (IDE) with the USA Food and Drug Administration (FDA). The study treatment uses MagForce's proprietary NanoTherm(TM) technology to completely ablate Prostate Cancer lesions. The purpose of the proposed study, that will enroll up to 120 men, is to demonstrate that NanoTherm(TM) can ablate cancer lesions for patients who have Gleason Score 7 Prostate Cancer and are under active surveillance. By ablating the lesions, patients will be able to maintain active surveillance and avoid surgery and other treatments all with well-known side effects like impairment of urinary and sexual functions. Dr. Ian M. Thompson, Jr., Director, Cancer Therapy and Research Center, a National Cancer Institute-designated Cancer Center at the University of Texas Health Science Center at San Antonio and Dr. Dan W. Lin, Chief of Urologic Oncology and Professor in the Department of Urology at the University of Washington School of Medicine in Seattle have agreed to be Co-Principal Investigators. Larry Kessler, Sc.D., Professor and Chair of the Department of Health Services, School of Public Health at the University of Washington is also a Co-Investigator overseeing the regulatory submission and registration processes. This is indeed a significant milestone for MagForce USA, Inc. and MagForce AG. Men enrolled in active surveillance programs could potentially benefit from this focal therapy after registration in the USA. We believe the registration clinical trial will prove that NanoTherm(TM) therapy can fulfill the desired outcome. We look forward to working with the FDA and advancing the registration process in the USA. Investor Relations Since we published our first shareholder letter of 2015 in February, we have presented at: Morgan Stanley European MedTech & Services Conference in London, 27th Annual ROTH Conference in Dana Point, USA, Bank of America Merrill Lynch 2015 Health Care Conference in Las Vegas, Berenberg European Conference USA in Tarrytown, and 19th MKK - Munich Capital Market Conference in Germany. We have also conducted roadshows in: Paris, Frankfurt, London, Vienna, Munich. In June and during the second half of 2015, we will present at: Deutsche Bank dbAccess German, Swiss & Austrian Conference 2015 in Berlin, Berenberg & Goldman Sachs European Medtech & Healthcare Services Conference 2015 in London, Berenberg and Goldman Sachs Fourth Annual German Corporate Conference in Munich and at the German Equity Forum in Frankfurt. Additionally, Berenberg and Hauck & Aufthäuser have presented updates and GBC AG initiated research coverage. All reports are listed on our website www.magforce.com. The published research reports have price targets ranging from 8.25 - 13.2 euros/share. To keep our shareholders informed, we plan to institute a regular shareholder conference call during the second half of 2015. Please inform my office at bread@magforce.com if you would like to attend the first conference call targeted for September 2015. Dear Shareholders, in summary, we are successfully moving forward on our exciting and challenging path to develop NanoTherm(TM) therapy into a globally valued therapy for the treatments of Glioblastoma and Prostate Cancer. 2015 continues to be a very important and exciting year for MagForce's development. I would like to thank our talented and dedicated staff who are creating the successes. Again, thank you for your interest and support of MagForce. Sincerely, Dr. Ben Lipps Chief Executive Officer & Chairman of the Management Board" â About MagForce AG and MagForce USA, Inc. MagForce AG, listed in the entry standard of the Frankfurt Stock Exchange (MF6, ISIN: DE000A0HGQF5), together with its subsidiary MagForce USA, Inc. is a leading medical device company in the field of nanomedicine focused on oncology. The Group's proprietary NanoTherm(TM) therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. Mithril Capital Management, a growth-stage technology fund founded by Ajay Royan and Peter Thiel, along with MagForce AG, are investors and strategic partners in MagForce USA, Inc. NanoTherm(TM), NanoPlan(R), and NanoActivator(R) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm(TM), NanoPlan(R), and NanoActivator(R) are trademarks of MagForce AG in selected countries. For more information, please visit: www.magforce.com. Disclaimer This release may contain forward-looking statements and information which may be identified by formulations using terms such as "expects", "aims", "anticipates", "intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-looking statements are based on our current expectations and certain assumptions, which may be subject to a variety of risks and uncertainties. The results actually achieved by MagForce AG may substantially differ from these forward-looking statements. MagForce AG assumes no obligation to update these forward-looking statements or to correct them in case of developments, which differ from those, anticipated. Contact: Anne Hennecke MC Services AG T +49 211 529252-22 F +49 211 529252-29 Email: anne.hennecke@mc-services.eu --------------------------------------------------------------------- 08.06.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MagForce AG Max-Planck-StraÃe 3 12489 Berlin Germany Phone: +49 (0)30 308 380 0 Fax: +49 (0)30 308 380 99 E-mail: info@magforce.com Internet: www.magforce.com ISIN: DE000A0HGQF5 WKN: A0HGQF Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt End of News DGAP News-Service --------------------------------------------------------------------- 366149 08.06.2015
DGAP-News: MagForce AG: MagForce AG Publishes its Second
Top 10 Most Recent News Articles
A&G Management's Bold New Era with WPM Partnership
Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...
Continue Reading
Sungrow's Keeper Family: Revolutionizing C&I Energy Storage
The Next Level in Energy Storage Solutions Well, folks, Sungrow's got something up its sleeve that's shaking up the energy storage scene. They're calling it the 'Keeper Family,' and if you’re deep into commercial and industrial (C&I) energy storage, this might just be your ticket to topping those profit charts. Launched at the Global Energy Pioneer Summit 2026, their...
Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact
A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....
Continue Reading
Nevada Expands Rural Youth Mental Health Access
Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...
Continue Reading
China's APEC Summit: A Catalyst for Business Growth?
A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...
Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List
Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...
Continue Reading
SOBER CAFFEINE™: Modern Energizer Without the Bull
Shed the Cans and Embrace Convenience I'm sure you've had a run-in with the standard energy drink routine. You know, the massive cans, a gut punch of sugar, and the inevitable crash that follows? Sobriety Supplements LLC decided enough is enough and rolled out something that just makes sense—SOBER CAFFEINE™ capsules. This little pill is a godsend for folks sick of...
Continue Reading
WHP Global's Japan Move: A Major Toy Market Play
New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...
Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely
Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...
Continue Reading
Mall of America Strives for World Record This Black Friday
History in the Making at Mall of America Yeah, it seems these folks are not just about shopping anymore. The Mall of America is aiming to set the bar high this Black Friday, eyeing a GUINNESS WORLD RECORDS title for the most people holding up the same shopping bag all at once. Imagine a thousand people, synchronized like a flash mob—only with shopping bags instead of...
Continue ReadingTop 5 Most Recently Viewed Articles
Anticipating Greenlight Capital Re's Q4 and Annual Results
Greenlight Capital Re, Ltd. Plans Future Financial Release Greenlight Capital Re, Ltd. (NASDAQ: GLRE), a leading multiline property and casualty insurer and reinsurer, has announced its schedule for releasing financial results for the fourth quarter and full year, which ended on December 31, 2024. The company is set to disclose these important results after the market...
Continue Reading
Integral Ad Science Holdings Faces Shareholder Lawsuit Insights
Integral Ad Science's Shareholder Alert Integral Ad Science Holding Corp. (NASDAQ: IAS) is currently grappling with a significant legal challenge. A class action lawsuit has been filed against the company, alerting shareholders of their rights and options. Investors linked to the company should be aware of these developments as they navigate their positions in the market....
Continue Reading
Corcoran Expands Internationally with New Franchise Launch
Corcoran Launches New Franchise in Mexico Corcoran Group LLC has taken a significant step in its expansion strategy by announcing the launch of its first franchise in Mexico, named Corcoran The Baja Real Estate Co. Led by Blake Harrington, this new brokerage is set to serve clients in the vibrant area surrounding Cabo San Lucas. This strategic move underscores Corcoran's...
Continue Reading
Titan Mining Announces Details for Upcoming AGM Meeting
Titan Mining Corporation's Upcoming Annual General Meeting Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) is set to hold its annual general meeting soon, a much-anticipated event for shareholders and stakeholders alike. The date is indeed significant as it marks an opportunity for the company to engage directly with its investors. Meeting Details and Importance The...
Continue Reading
Investing in EQT: A 20-Year Journey of Growth and Returns
Understanding EQT Corporation's Investment Landscape EQT Corporation (NYSE: EQT) has shown substantial growth in the investment landscape over the past two decades. Over this period, EQT has consistently outperformed the market by 10.28% on an annualized basis, resulting in an impressive average annual return of 18.48%. This growth has contributed to EQT's current market...
Continue Reading